Medictal Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Faridabad, Haryana, India, established in 2024.
2024 Faridabad, Haryana, India Active
Last Updated:
Access Report
About Medictal Pharmaceuticals Private Limited

Medictal Pharmaceuticals Private Limited, a active private limited company, was established on 19 March 2024 in Faridabad, Haryana, India. it holds CIN: U46497HR2024PTC119973. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mausami Chaudhari (Director), Upendra Kumar Yadav (Director), Arbind Kumar Singh (Additional Director). Past directors included Mausami Chaudhari. It is based at No. 1, Dheeraj Nagar,, Aitmadpur,, Faridabad, Haryana, 121002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497HR2024PTC119973

  • Registration Number

    119973

  • Incorporation Date

    19 March 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 11 Months
Company report

Medictal Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medictal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medictal Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mausami Chaudhari Director 19 Mar 2024 Current
Upendra Kumar Yadav Director 19 Mar 2024 Current
Arbind Kumar Singh Additional Director 20 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 11 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medictal Pharmaceuticals.

Enhance accessibility to Medictal Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medictal Pharmaceuticals revenue growth over time
Medictal Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medictal Pharmaceuticals?

Unlock access to Medictal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medictal Pharmaceuticals?

Unlock and access historical data on people associated with Medictal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medictal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medictal Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medictal Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Arbind Kumar Singh was appointed as a Additional Director was appointed as a Additional Director on 20 Feb 2025 & has been associated with this company since 1 year 3 days . was completed.

  • Director Appointment

    Mausami Chaudhari was appointed as a Director was appointed as a Director on 19 Mar 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Upendra Kumar Yadav was appointed as a Director was appointed as a Director on 19 Mar 2024 & has been associated with this company since 1 year 11 months . was completed.

  • Company Incorporation

    Medictal Pharmaceuticals Private Limited was registered on 19 Mar 2024 with Roc Delhi & aged 1 year 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medictal Pharmaceuticals Private Limited?

The CIN of Medictal Pharmaceuticals Private Limited is U46497HR2024PTC119973.

Where is Medictal Pharmaceuticals Private Limited headquartered?

Medictal Pharmaceuticals Private Limited is headquartered at No. 1, Dheeraj Nagar,, Aitmadpur,, Faridabad, Haryana, 121002.

When was Medictal Pharmaceuticals Private Limited incorporated?

Medictal Pharmaceuticals Private Limited was incorporated on 19 March 2024.

Who are the current directors of Medictal Pharmaceuticals Private Limited?

The current directors of Medictal Pharmaceuticals Private Limited are

Is Medictal Pharmaceuticals Private Limited a listed company?

Medictal Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Medictal Pharmaceuticals Private Limited?

The authorized capital of Medictal Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available